Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8
RESEARCH TOOLSreports
Holding DE:BM8?
Track your performance easily
Trend: ▲ Hedge Funds Increased Holdings by 1.9M Shares Last Quarter
Hedge Fund Holdings in BM8
Based on the 13F filings of 487 Hedge Funds submitted to the SEC.
See how hedge fund holdings have changed over the past year. The columns represent the number of shares owned by hedge funds.
Hedge Fund Confidence Signal
Very Positive'%3E%3C/stop%3E%3Cstop offset='100%25' stop-color='rgba(59, 146, 255,0.1)'%3E%3C/stop%3E%3C/linearGradient%3E%3C/defs%3E%3Cpath d='M10,90 A60,60 0 0,1 170,90' fill='none' stroke='url(%23gradient)' stroke-width='20'%3E%3C/path%3E%3C/svg%3E)
Sold
Bought
A unique signal which shows hedge fund sentiment according to recent transactions.
Hedge Fund Activity
Activity
Any
Star Ranking
Any
FAQ
Which hedge funds hold BioMarin Pharmaceutical?
The hedge funds that hold the most shares in BioMarin Pharmaceutical are Theofanis Kolokotrones, John A. Gunn and Andreas Halvorsen.
Are hedge funds buying or selling DE:BM8?
In the last quarter hedge funds have Increased their holdings in BioMarin Pharmaceutical by 1.9M shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in BioMarin Pharmaceutical stock?
Warren Buffet currently does not own shares in BioMarin Pharmaceutical.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here